MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01882nam a22002777i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250819143154.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250730s2021 us a|||fr|||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781639271955 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-GaU |
| Transcribing agency |
EG-GaU |
| Modifying agency |
EG-GaU |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
616.106 |
| Item number |
H.L.L |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Henry, Louis, |
| Relator term |
author. |
| 9 (RLIN) |
60850 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Liver Fibrosis: |
| Remainder of title |
assessment and integrative treatment / |
| Statement of responsibility, etc. |
Louis Henry. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
[United States] : |
| Name of producer, publisher, distributor, manufacturer |
American Medical Publishers, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
248 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
28 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| Carrier type code |
nc |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes references on diagnostic approaches, pharmacological and lifestyle interventions.<br/> |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Liver fibrosis is a medical condition wherein the liver becomes scarred and is unable to function properly. It is the first stage of liver scarring and has the potential to develop into liver cirrhosis. Medications and lifestyle changes can prevent the advancement of liver fibrosis. It is often not diagnosed during its initial stages, since symptoms do not occur until the severity increases. Symptoms in the advanced stages may include loss of appetite, difficulty in thinking clearly, fluid buildup in the legs or stomach, jaundice, nausea, weight loss and weakness. This book provides significant information of this discipline to help develop a good understanding of liver fibrosis. Its objective is to give a general view of the different assessment and integrative treatment methods of this disease. This book will serve as a reference to a broad spectrum of readers.<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Hepatology. |
| 9 (RLIN) |
60851 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Integrative medicine. |
| 9 (RLIN) |
60852 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medical reference works. |
| 9 (RLIN) |
60823 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |